Product class: Authorized package
Medicinal product class: For human use
Package code: 1776012
Name of medicinal product: LEVOTHYROXINE ACCORD
Active substances:
Levothyroxine sodium
Estonian, English, Latin
ATC code: H03AA01
Dosage form: tablet
Route of administration: oral use
Strengh: 88mcg
Amount in package: 200TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: * Treatment of benign euthyroid goitre * Prophylaxis of relapse after surgery for euthyroid goitre, depending on the post-operative hormone status * Substitution therapy in hypothyroidism * Suppression therapy in thyroid cancer * Concomitant supplementation during anti-thyroid drug treatment of hyperthyroidism
Safety features: Yes
Summary of product characteristics (SPC):  (last updated 17 October 2023)
Package information leaflet (PIL): EST  (last updated 17 October 2023)
Labelling:  (last updated 24 March 2020)
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Accord Healthcare B.V. 
Marketing authorization number: 1003320 
Marketing authorization issued on: 24 March 2020 
Marketing authorization expires on: 24 March 2025 
Marketing authorization procedure type: Decentralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Description Additional condition
Perearsti õel on õigus välja kirjutada Välja arvatud esmane retsept
Entry/Changing date: 17 April 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription